CERENO SCIENTIFIC AB B (4A1) — Working Capital to Net Assets Ratio
CERENO SCIENTIFIC AB B (4A1) has a Working Capital to Net Assets ratio of -21.1% as of June 2026. Working capital of €-41.89 Million (current assets of €44.24 Million minus current liabilities of €86.12 Million) is measured against net assets of €198.40 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
CERENO SCIENTIFIC AB B Working Capital to Net Assets (2021–2025)
This chart shows how CERENO SCIENTIFIC AB B's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at -21.1%, reflecting working capital of €-41.89 Million against net assets of €198.40 Million EUR. For the complete balance sheet picture, see how large is CERENO SCIENTIFIC AB B's balance sheet.
Annual Working Capital to Net Assets for CERENO SCIENTIFIC AB B (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for CERENO SCIENTIFIC AB B from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read 4A1 current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 21.1% | €53.27 Million | €252.60 Million | €78.35 Million | €25.08 Million | ▼ -31.8 pp |
| 2024 | 52.9% | €101.55 Million | €191.93 Million | €133.00 Million | €31.45 Million | ▲ +22.6 pp |
| 2023 | 30.3% | €65.54 Million | €216.42 Million | €88.70 Million | €23.16 Million | ▲ +3.0 pp |
| 2022 | 27.2% | €54.89 Million | €201.51 Million | €68.63 Million | €13.74 Million | ▼ -20.4 pp |
| 2021 | 47.6% | €80.96 Million | €170.06 Million | €91.24 Million | €10.27 Million | — |